Shogo Kobayashi
The University of Osaka, Osaka International Cancer Institute
Papers
2
Total Citations
11
H-Index
2
About
Shogo Kobayashi is a leading surgical oncologist whose research focuses on advancing minimally invasive techniques for gastrointestinal and pancreatic malignancies. His most impactful work centers on the oncologic safety of laparoscopic and robotic approaches, particularly for pancreatic cancer. Kobayashi is the principal investigator of the landmark JCOG2202 (LAPAN) study, a multi-institutional randomized phase III trial comparing minimally invasive distal pancreatectomy (MIDP) to open surgery for pancreatic cancer. This pivotal study, cited 9 times since its 2024 publication, addresses the critical evidence gap regarding the oncologic equivalence of MIDP, directly shaping global surgical guidelines. Additionally, his 2025 work on conversion surgery following zolbetuximab-based chemotherapy for CLDN18.2-positive gastroesophageal junction cancer highlights his translational focus on integrating targeted therapies with surgical resection. Through these contributions, Kobayashi is defining the future of precision surgery in hepato-pancreato-biliary oncology, demonstrating that minimally invasive techniques can be both safe and effective for complex malignancies.
Research Focus
Key Achievements
Top Papers
- 1
- 2